Article info

Download PDFPDF

Clinical case
Tocilizumab in the treatment of mixed connective tissue disease and overlap syndrome in children

Authors

  • Natalia Cabrera Department of Pediatric Rheumatology, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Claude Bernard University Lyon 1, University of Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Agnes Duquesne PubMed articlesGoogle scholar articles
  • Marine Desjonquères Department of Pediatric Rheumatology, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Claude Bernard University Lyon 1, University of Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Jean-Paul Larbre Department of Rheumatology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Claude Bernard University Lyon 1, University of Lyon, Pierre-Bénite, France PubMed articlesGoogle scholar articles
  • Jean-Christophe Lega Department of Internal and Vascular Medicine, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Claude Bernard University Lyon 1, University of Lyon, Lyon, France Laboratoire de Biométrie et Biologie Evolutive, CNRS, Claude Bernard University Lyon 1, University of Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Nicole Fabien Department of Immunology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Alexandre Belot Department of Pediatric Rheumatology, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Claude Bernard University Lyon 1, University of Lyon, Lyon, France INSERM U1111 PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Alexandre Belot; alexandre.belot{at}chu-lyon.fr
View Full Text

Citation

Cabrera N, Duquesne A, Desjonquères M, et al
Tocilizumab in the treatment of mixed connective tissue disease and overlap syndrome in children

Publication history

  • Received February 26, 2016
  • Revision received June 28, 2016
  • Accepted July 11, 2016
  • First published September 15, 2016.
Online issue publication 
September 15, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.